Dr. Amy L. Gin, MD

Dr. Gin practices at Prima Medical Foundation in Larkspur, California.

Dr. Gin's NPI, 1598080442, was assigned on April 5, 2010. Dr. Gin graduated from New York Medical College in 2007. Dr. Gin holds California license A108101.

Dr. Gin's primary practice is Prima Medical Foundation, at 2 Bon Air Rd, Larkspur, CA 94939 in Marin County. The practice phone is (415) 884-1840.

Dr. Gin's primary practice is Prima Medical Foundation in Larkspur, California. Dr. Gin is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Gin to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gin practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Gin's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Gin is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Gin's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Gin treats.

CMS data shows 4,305 Medicare services from Dr. Gin across 29 procedure codes in 2024, for 1,010 Medicare patients. Medicare paid $226,634 for them.

CMS counts 1,010 Medicare patients who saw Dr. Gin in 2024. The largest group is 75 to 84, with 469 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gin's median patient age at 77, with 50% women.

In 2024, Dr. Gin wrote 5,903 Medicare Part D claims for 904 patients. 87% of them were for generic drugs. CMS names the drug for 5,610 of them, across 47 drugs with 11 or more claims each, at $1,067,038 in total drug cost. In 2023, CMS named 5,148 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Gin for performance year 2024. CMS lists Dr. Gin as offering telehealth. CMS counts 39 procedures of coronary angioplasty and stenting by Dr. Gin, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Gin, published from 2014 to 2023. 2019 was the busiest year, with 2. The most frequent topics are Cell Line, Tumor, Exosomes and MicroRNAs. Dr. Gin has published most often in Cell Commun Signal. Dr. Gin's most frequent co-authors are Mazen Saadi Albaghdadi, MD, Hala Chaaban, MD and Brian Burns Ghoshhajra, MD.

CMS Open Payments shows 204 general payments to Dr. Gin from 21 drug and device companies from 2016 to 2025. Grants make up the largest share, 41% of the total. Medtronic Vascular, Inc. paid the most, $14,074.

Dr. Gin graduated from New York Medical College in 2007.

Dr. Gin is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.